ENDOSCAPE

ENDOSCAPE is a collaborative biotechnology project consisting of 12 European partners, aimed at developing a beyond state of the art clinically applicable gene delivery technology. The ENDOSCAPE technology will have a major impact on the therapeutic opportunities for current and future drugs for a broad range of diseases and large patient groups. The non-viral based ENDOSCAPE technology will enhance therapeutic efficacy with in a more cost-effective manner thereby reducing costs of healthcare, improving the health of patients worldwide, and strengthening the competitive landscape of the EU in the worldwide quest for such an advanced technology. The project is funded by the European Commission under the Horizon 2020 initiative, with the grant agreement ID: 825730.